Should you buy PASG stock?

Last updated:

Based on market data through , StockInvest.us rates Passage Bio, Inc. (PASG) as a Strong Sell Candidate with a technical score of -5.36 on its -10 to +10 scale. This is a downgrade from Sell in the previous daily evaluation.

  • Sell signal since
  • Price since signal Down 6.29%
  • 3-month trend forecast Down 16.73%
  • Strong Sell Candidate -5.36
AI Analysis AI Analysis of PASG AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PASG to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Passage Bio, Inc. stock downgraded from Sell Candidate to Strong Sell Candidate after Monday trading session
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Aug 05, 2026 Loss -6.29%

The Passage Bio, Inc. stock price fell by -1.82% on the last day (Monday, 10th Aug 2026) from $4.40 to $4.32. During the last trading day the stock fluctuated 6.25% from a day low at $4.32 to a day high of $4.59. The price has fallen in 7 of the last 10 days and is down by -6.49% for this period. Volume has increased on the last day by 12 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 18 thousand shares were bought and sold for approximately $79.85 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.73% during the next 3 months and, with a 90% probability hold a price between $2.74 and $4.60 at the end of this 3-month period.

PASG Signals & Forecast

There are few to no technical positive signals at the moment. The Passage Bio, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.47 and $4.77. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, June 23, 2026, and so far it has fallen -29.41%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Passage Bio, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Passage Bio, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.270 between high and low, or 6.25%. For the last week, the stock has had daily average volatility of 5.52%.

Passage Bio, Inc. is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PASG) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Passage Bio, Inc. to open at $4.41, and during the day (based on 14 day Average True Range), to move between $4.17 and $4.47, which gives a possible trading interval of +/-$0.296 (+/-7.10%) up or down from last closing price. If Passage Bio, Inc. takes out the full calculated possible swing range there will be an estimated 7.10% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $4.33, some $0.0100 (0.23%) from the current price of $4.32, our system finds the risk reward not very attractive.

Is Passage Bio, Inc. stock A Buy?

Passage Bio, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.362 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $4.41 ( 2.08%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PASG Performance

Trading levels for PASG

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 4.68 8.33%
R2 4.58 5.95%
R1 4.51 4.47%
Price 4.32
S1 4.31 -0.304%
S2 4.24 -1.78%
S3 4.14 -4.17%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.03 16.44%
R2 4.70 8.80%
R1 4.33 0.231%
Price 4.32
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Passage Bio, Inc. Stock and on which exchange is it traded?
The symbol for Passage Bio, Inc. is PASG and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Passage Bio, Inc. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Passage Bio, Inc. (PASG) as a Strong Sell Candidate with a technical score of -5.36 on its -10 to +10 scale. This is a downgrade from Sell in the previous daily evaluation. Since the Sell signal began on Aug 05, 2026, the price has fallen 6.29%. The current 3-month trend forecast projects a fall of 16.73%.

How to buy Passage Bio, Inc. Stock?
Passage Bio, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Passage Bio, Inc. Stock.

What's the current price of Passage Bio, Inc. Stock?
As of the end of day on the Aug 10, 2026, the price of an Passage Bio, Inc. (PASG) share was $4.32.

What is the 52-week high and low for Passage Bio, Inc. Stock?
The 52-week high for Passage Bio, Inc. Stock is $20.00 and the 52-week low is $3.29.

What is the market capitalization of Passage Bio, Inc. Stock?
As of the Aug 10, 2026, the market capitalization of Passage Bio, Inc. is 13.879M.

When is the next earnings date for Passage Bio, Inc.?
The upcoming earnings date for Passage Bio, Inc. is Nov 16, 2026.
Click to get the best stock tips daily for free!
ABOUT PASSAGE BIO, INC.
Passage Bio
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 capsid to deliver to the brain a functional granulin (GRN) and gene encoding progranulin (PGRN) for the...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE